OIS VIRTUAL PUBLIC COMPANY SHOWCASE

July 16, 2020

Day
Hour
Minute
Second

12TH ANNUAL OIS 2020

NOVEMBER 12, 2020 | LAS VEGAS, NV

The Ophthalmology Innovation Summit began in 2009 and now unites over 1,200 Corporate, Clinical and Capital leaders to collaborate on the development and commercialization of innovative drugs, devices and diagnostics to address unmet vision disorders.

The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

LATEST NEWS

Keeping an "Eye on Innovation" Through News & Analysis

OIS Index Q2

July 9 2020

OIS Index Rallies Back from COVID-Driven Decline

The OIS Index of ophthalmic stocks staged a strong comeback in Q2, gaining 21.4%, in line with the overall US stock market as measured by ...
AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol

July 9 2020

AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol

Weeks after completing its acquisition of Allergan, AbbVie is seeking a meeting with the US Food and Drug Administration to talk about the next steps ...
With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering

July 1 2020

With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering

Oyster Point Pharma has taken two big steps recently to advance development of its OC-01 nasal-spray candidate to treat dry eye disease: the closing of ...
Necessity Is the Mother of Collaborative Care between Optometrists and Ophthalmologists

June 17 2020

Necessity Is the Mother of Collaborative Care between Optometrists and Ophthalmologists

Collaborative care models – optometrists and ophthalmologists working together on patient care – are emerging as a way to reduce some of the strain caused ...
With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

June 10 2020

With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

Most transformations are predictable: A caterpillar will turn into a butterfly; a cell will be genetically altered should extraneous DNA enter its membrane. Predictable would ...
OIS-Index

June 3 2020

May Extends April’s Rebound from March Lows

The OIS Index of ophthalmic stocks gained 7.9% in May, following a 12.2% gain in April, extending the rebound from the mid-March lows. Over the ...

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.